Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinoma

HPB

Volumn 7, Issue 4, 2005, Pages 283-288

  Baskin Bey, E S ^a,b   Devarbhavi, H C ^a   Nagorney, D M ^b   Farnell, M B ^b   Donohue, J H ^b   Sanderson, S O ^b   Stadheim, L M ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Bile duct strictures; Cholangiocarcinoma; HIF 1 alpha; Sarcoidosis

Indexed keywords

CA 19-9 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER RESECTION; MALE; MEDICAL RECORD REVIEW; PATHOGENESIS; REVIEW; SEX RATIO;

EID: 33745108829     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820500292954     Document Type: Review

References (23)

1. Gores, G. (2003) Cholangiocarcinoma: Current concepts and insights Hepatology, 37, pp. 961-9.
2. Hadjis, N and Collier, N and Blumgart, L. (1985) Malignant masquerade at the hilum of the liver Br J Surg, 72, pp. 659-61.
3. Albert, M and Steinberg, W and Henry, J. (1988) Elevated serum levels of tumor marker CA 19-9 in acute cholangitis Dig Dis Sci, 33, pp. 1223-5.
4. Bos, R and van der Groep, P and Greijer, A and Shvarts, Av and Meijer, S and Pinedo, H and (1988) Levels of hypoxia inducible factor-1-alpha independently predict prognosis in patients with lymph node negative breast carcinoma Cancer, 97, pp. 1573-81.
5. Bos, R and Zhong, H and Hanrahan, C and Mommers, E and Semeza, G and Pinedo, H and et al. (2001) Levels of hypoxia-inducible factor-1-alpha during breast carcinogenesis J Natl Cancer Inst, 93, pp. 309-14.
6. Bismuth, H and Corlette, M. (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver Surg Gynecol Obstet, 140, pp. 170-8.
7. Sobin, L and Wittekind, C. TNM classification of malignant tumors 6th.
8. Verbeek, P and van Leeuwen, D and de Wit, L and Reeders, J and Smits, N and Bosma, A and (1992) Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors Surgery, 112, pp. 866-71.
9. Murr, M and Gigot, J and Nagorney, D and Harmsen, W and Ilstrup, D and Farnell, M. (1999) Long-term results of biliary reconstruction after laparoscopic bile duct injuries Arch Surg, 134, pp. 604-9. discussion 609-10
10. Terblanche, J and Allison, H and Northover, J. (1983) An ischemic basis for biliary strictures Surgery, 94, pp. 52-7.
11. Lee, S and Wolf, P and Escudero, R and Deutsch, R and Jamieson, S and Thistlethwaite, P. (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction [see comment] N Engl J Med, 342, pp. 626-33.
12. Kamal, G. (1998) Sarcoidosis of the liver and bile ducts Mayo Clinic Proc, 73, pp. 467-72.
13. Imtiaz, A and Levenson, S and Ferrell, L and Bass, N. (1997) Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis: Case report and review of the literature Dig Dis Sci, 42, pp. 1295-301.
14. Rezeig, M and Fashir, B. (1997) Biliary tract obstruction due to sarcoidosis: A case report Am J Gastroenterol, 92, pp. 527-8.
15. Cherqui, D and Palazzo, L and Piedbois, P and Charlotte, F and Duvoux, C and Duron, J and (1994) Common bile duct stricture as a late complication of upper abdominal radiotherapy [see comment] J Hepatol, 20, pp. 693-7.
16. Ravindra, K and Stringer, M and Prasad, K and Kinsey, S and Lodge, J. (2003) Non-Hodgkin lymphoma presenting with obstructive jaundice Br J Surg, 90, pp. 845-9.
17. Lillemoe, K and Pitt, H and Cameron, J. (1992) Current management of benign bile duct strictures Adv Surg, 25, pp. 119-74.
18. Gerhards, M and Vos, P and van Gulik, T and Rauws, E and Bosma, A and Gouma, D. (2001) Incidence of benign lesions in patients resected for suspicious hilar obstruction Br J Surg, 88, pp. 48-51.
19. Farrell, R and Agarwal, B and Brandwein, S and Underhill, J and Chuttani, R and Pleskow, D. (2002) Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures Gastrointest Endosc, 56, pp. 681-7.
20. Kim, H and Lee, K and Kim, S and Lee, J and Lim, J and Paik, S and (2003) Differential diagnosis of intrahepatic bile duct dilatation without demonstrable mass on ultrasonography or CT: Benign versus malignancy J Gastroenterol Hepatol, 18, pp. 1287-92.
21. Khan, S and Davidson, B and Goldin, R and Pereira, S and Rosenberg, W and Taylor-Robinson, S and (2002) British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut, 51 (Suppl 6), pp. VI1-9.
22. Schwartz, D and Wiersema, M. (2002) The role of endoscopic ultrasound in hepatobiliary disease Curr Gastroenterol Rep, 4, pp. 72-8.
23. Rumalla, A and Baron, T and Leontovich, O and Burgart, L and Yacavone, R and Therneau, T and et al. (2001) Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis Mayo Clin Proc, 76, pp. 29-33.